The role of mitochondrial dysfunction in cardiovascular disease: a brief review

References

• Heart Disease and Stroke Statistics 2017 At-a-Glance. American Heart Association. [Internet]; 2017 [cited 2017 Aug 20]. Available from: https://www.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_491265.pdf.
   Google Scholar
• European Cardiovascular Disease Statistics 2017. European Heart Network. [Internet]; 2017 [cited 2017 Aug 20]. Available from: http://www.ehnheart.org/cvd-statistics.html.
   Google Scholar
• Jazwinski SM. The retrograde response: when mitochondrial quality control is not enough. Biochim Biophys Acta. 2013;1833:400–409.
   PubMed Web of Science ®Google Scholar
• Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. Am J Med Genet. 2001;106:94–101.
   PubMed Web of Science ®Google Scholar
• Sun N, Finkel T. Cardiac mitochondria: a surprise about size. J Mol Cell Cardiol. 2015;82:213–215.
   PubMed Web of Science ®Google Scholar
• Riva A, Tandler B, Loffredo F, et al. Structural differences in two biochemically defined populations of cardiac mitochondria. Am J Physiol Heart Circ Physiol. 2005;289:H868–H772.
   PubMed Web of Science ®Google Scholar
• Amchenkova AA, Bakeeva LE, Chentsov YS, et al. Coupling membranes as energy-transmitting cables. I. Filamentous mitochondria in fibroblasts and mitochondrial clusters in cardiomyocytes. J Cell Biol. 1988;107:481–495.
   PubMed Web of Science ®Google Scholar
• Ong SB, Hausenloy DJ. Mitochondrial morphology and cardiovascular disease. Cardiovasc Res. 2010;88:16–29.
   PubMed Web of Science ®Google Scholar
• Hoppel CL, Tandler B, Fujioka H, et al. Dynamic organization of mitochondria in human heart and in myocardial disease. Int J Biochem Cell Biol. 2009;41: 1949–1956.
   PubMed Web of Science ®Google Scholar
• Kraus B, Cain H. Giant mitochondria in the human myocardium-morphogenesis and fate. Virchows Arch, B, Cell Pathol. 1980;33:77–89.
   Google Scholar
• Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 2001; 114:867–874.
   PubMed Web of Science ®Google Scholar
• Stadhouders AM, Jap PH, Winkler HP, et al. Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies. Proc Natl Acad Sci USA. 1994;91:5089–5093.
   PubMed Web of Science ®Google Scholar
• Ong SB, Subrayan S, Lim SY, et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 2010;121:2012–2022.
   PubMed Web of Science ®Google Scholar
• Karbowski M, Lee YJ, Gaume B, et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol. 2002;159:931–938.
   PubMed Web of Science ®Google Scholar
• Dominic EA, Ramezani A, Anker SD, et al. Mitochondrial cytopathies and cardiovascular disease. Heart. 2014;100:611–618.
   PubMed Web of Science ®Google Scholar
• Boveris A, Cadenas E, Stoppani AO. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J. 1976;156:435–444.
   PubMed Web of Science ®Google Scholar
• Penna C, Mancardi D, Rastaldo R, et al. Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta. 2009; 1787:781–793.
   PubMed Web of Science ®Google Scholar
• Victor VM, Apostolova N, Herance R, et al. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Curr Med Chem. 2009;16:4654–4667.
   PubMed Web of Science ®Google Scholar
• Saraste M. Oxidative phosphorylation at the fin de siècle. Science. 1999;283:1488–148893.
   PubMed Web of Science ®Google Scholar
• Balaban RS, Kantor HL, Katz LA, et al. Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science. 1986;232: 1121–1123.
   PubMed Web of Science ®Google Scholar
• Jacobus WE. Respiratory control and the integration of heart high-energy phosphate metabolism by mitochondrial creatine kinase. Annu Rev Physiol. 1985; 47:707–725.
   PubMed Web of Science ®Google Scholar
• Soboll S, Brdiczka D, Jahnke D, et al. Octamer-dimer transitions of mitochondrial creatine kinase in heart disease. J Mol Cell Cardiol. 1999;31:857–866.
   PubMed Web of Science ®Google Scholar
• Ashrafian H. Cardiac energetics in congestive heart failure. Circulation. 2002;105:e44–e45.
   PubMed Web of Science ®Google Scholar
• Zhang L, Keung W, Samokhvalov V, et al. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta. 2010;1801:1–22.
   PubMed Web of Science ®Google Scholar
• Stanley WC. Rationale for a metabolic approach in diabetic coronary patients. Coron Artery Dis. 2005;16 (Suppl 1):S11–S15.
   PubMed Web of Science ®Google Scholar
• Neglia D, De Caterina A, Marraccini P, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2007;293:H3270–H3278.
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312.
   PubMed Web of Science ®Google Scholar
• Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996;79:949–956.
   PubMed Web of Science ®Google Scholar
• Mughal W, Dhingra R, Kirshenbaum LA. Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart. Curr Hypertens Rep. 2012;14: 540–547.
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Fukunaga K. Activation of HtrA2, a mitochondrial serine protease mediates apoptosis: current knowledge on HtrA2 mediated myocardial ischemia/reperfusion injury. Cardiovasc Ther. 2008;26:224–232.
   PubMed Web of Science ®Google Scholar
• Dorn GW. 2nd Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors. J Cardiovasc Trans Res. 2010;3:374–383.
   PubMed Web of Science ®Google Scholar
• Dorn GW, 2nd, Kirshenbaum LA. Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L. Oncogene. 2008;27(Suppl 1):S158–S167.
   PubMed Web of Science ®Google Scholar
• Khan MU, Cheema Y, Shahbaz AU, et al. Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states. Pflugers Arch. 2012;464:123–131.
   PubMed Web of Science ®Google Scholar
• Vásquez-Trincado C, García-Carvajal I, Pennanen C, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol (Lond). 2016;594:509–525.
   Google Scholar
• Kane LA, Lazarou M, Fogel AI, et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol. 2014;205:143–153.
   PubMed Web of Science ®Google Scholar
• Lazarou M, Sliter DA, Kane LA, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309–314.
   PubMed Web of Science ®Google Scholar
• Campos JC, Bozi LH, Bechara LR, et al. Mitochondrial quality control in cardiac diseases. Front Physiol. 2016;7:479
   PubMed Web of Science ®Google Scholar
• Culic O, Gruwel ML, Schrader J. Energy turnover of vascular endothelial cells. Am J Physiol. 1997;273: C205–C213.
   PubMed Web of Science ®Google Scholar
• Davidson SM. Endothelial mitochondria and heart disease. Cardiovasc Res. 2010;88:58–66.
   PubMed Web of Science ®Google Scholar
• Kurz DJ, Decary S, Hong Y, et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci. 2004;117:2417–2426.
   PubMed Web of Science ®Google Scholar
• Dai DF, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res. 2012;110:1109–1124.
   PubMed Web of Science ®Google Scholar
• Ahn SY, Choi YS, Koo HJ, et al. Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation. Biochim Biophys Acta. 2010;1800:275–281.
   PubMed Web of Science ®Google Scholar
• Chen KH, Guo X, Ma D, et al. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 2004;6:872–883.
   PubMed Web of Science ®Google Scholar
• Guo YH, Chen K, Gao W, et al. Overexpression of Mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. Biochem Biophys Res Commun. 2007;363:411–417.
   PubMed Web of Science ®Google Scholar
• Halestrap AP. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp. 1999;66:181–203.
   PubMedGoogle Scholar
• Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res. 2009;104:150–158.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1–222.
   PubMed Web of Science ®Google Scholar
• Billia F, Hauck L, Konecny F, et al. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci USA. 2011;108: 9572–9577.
   PubMed Web of Science ®Google Scholar
• Saito T, Asai K, Sato S, et al. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy. 2016;12:579–687.
   PubMed Web of Science ®Google Scholar
• Zak R, Rabinowitz M, Rajamanickam C, et al. Mitochondrial proliferation in cardiac hypertrophy. Basic Res Cardiol. 1980;75:171–178.
   PubMed Web of Science ®Google Scholar
• Goffart S, von Kleist-Retzow JC, Wiesner RJ. Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovasc Res. 2004;64:198–207.
   PubMed Web of Science ®Google Scholar
• Flarsheim CE, Grupp IL, Matlib MA. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol. 1996;271:H192–H202.
   PubMed Web of Science ®Google Scholar
• Sharov VG, Goussev A, Lesch M, et al. Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol. 1998; 30:1757–1762.
   PubMed Web of Science ®Google Scholar
• Casademont J, Miró O. Electron transport chain defects in heart failure. Heart Fail Rev. 2002;7:131–139.
   PubMedGoogle Scholar
• Karamanlidis G, Nascimben L, Couper GS, et al. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res. 2010;106: 1541–1548.
   PubMed Web of Science ®Google Scholar
• Ide T, Tsutsui H, Hayashidani S, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 2001;88:529–535.
   PubMed Web of Science ®Google Scholar
• Arbustini E, Diegoli M, Fasani R, et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol. 1998;153: 1501–1510.
   PubMed Web of Science ®Google Scholar
• Sheeran FL, Pepe S. Mitochondrial bioenergetics and dysfunction in failing heart. Adv Exp Med Biol. 2017;982:65–80.
   PubMed Web of Science ®Google Scholar
• Karamanlidis G, Garcia-Menendez L, Kolwicz SC, Jr, et al. Promoting PGC-1α-driven mitochondrial biogenesis is detrimental in pressure-overloaded mouse hearts. Am J Physiol Heart Circ Physiol. 2014;307: H1307–H1316.
   PubMed Web of Science ®Google Scholar
• Tandler B, Dunlap M, Hoppel CL, et al. Giant mitochondria in a cardiomyopathic heart. Ultrastruct Pathol. 2002;26:177–183.
   PubMed Web of Science ®Google Scholar